Paloma Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,700
| Closed | -$460K | – | 1367 |
|
|
2024
Q2 | $460K | Sell |
6,700
-21,392
| -76% | -$1.43M | 0.01% | 783 |
|
|
2024
Q1 | $2.06M | Buy |
28,092
+22,523
| +404% | +$1.73M | 0.11% | 231 |
|
|
2023
Q4 | $451K | Buy |
+5,569
| New | +$433K | 0.02% | 546 |
|
|
2022
Q2 | – | Sell |
-6,204
| Closed | -$384K | – | 1344 |
|
|
2022
Q1 | $369K | Buy |
6,204
+3,204
| +107% | +$205K | 0.01% | 1015 |
|
|
2021
Q4 | $218K | Buy |
+3,000
| New | +$207K | ﹤0.01% | 1558 |
|
|
2021
Q2 | – | Sell |
-18,719
| Closed | -$1.21M | – | 1958 |
|
|
2021
Q1 | $1.21M | Sell |
18,719
-8,979
| -32% | -$579K | 0.03% | 614 |
|
|
2020
Q4 | $1.61M | Buy |
+27,698
| New | +$1.67M | 0.04% | 427 |
|
|
2020
Q3 | – | Sell |
-173,081
| Closed | -$13.3M | – | 2227 |
|
|
2020
Q2 | $13.3M | Buy |
173,081
+128,137
| +285% | +$9.82M | 0.23% | 67 |
|
|
2020
Q1 | $3.36M | Sell |
44,944
-31,206
| -41% | -$2.16M | 0.19% | 70 |
|
|
2019
Q4 | $4.95M | Sell |
76,150
-4,836
| -6% | -$315K | 0.07% | 242 |
|
|
2019
Q3 | $5.13M | Sell |
80,986
-4,830
| -6% | -$316K | 0.11% | 153 |
|
|
2019
Q2 | $5.8M | Buy |
85,816
+42,620
| +99% | +$2.8M | 0.1% | 166 |
|
|
2019
Q1 | $2.81M | Buy |
43,196
+19,773
| +84% | +$1.31M | 0.07% | 328 |
|
|
2018
Q4 | $1.47M | Buy |
+23,423
| New | +$1.64M | 0.04% | 326 |
|
|
2018
Q2 | – | Sell |
-3,518
| Closed | -$248K | – | 1841 |
|
|
2018
Q1 | $266K | Sell |
3,518
-2,743
| -44% | -$218K | ﹤0.01% | 1673 |
|
|
2017
Q4 | $449K | Sell |
6,261
-21,634
| -78% | -$1.64M | 0.01% | 1372 |
|
|
2017
Q3 | $2.26M | Sell |
27,895
-5,205
| -16% | -$398K | 0.03% | 653 |
|
|
2017
Q2 | $2.34M | Sell |
33,100
-44,451
| -57% | -$2.96M | 0.03% | 652 |
|
|
2017
Q1 | $5.27M | Sell |
77,551
-218,699
| -74% | -$15.4M | 0.06% | 287 |
|
|
2016
Q4 | $21.2M | Buy |
296,250
+262,727
| +784% | +$19.5M | 0.21% | 54 |
|
|
2016
Q3 | $2.65M | Sell |
33,523
-343,207
| -91% | -$27.9M | 0.03% | 415 |
|
|
2016
Q2 | $31.4M | Buy |
376,730
+191,899
| +104% | +$17M | 0.35% | 30 |
|
|
2016
Q1 | $17M | Buy |
184,831
+137,554
| +291% | +$12.4M | 0.28% | 47 |
|
|
2015
Q4 | $4.78M | Sell |
47,277
-173,721
| -79% | -$18.1M | 0.13% | 129 |
|
|
2015
Q3 | $21.7M | Buy |
220,998
+103,651
| +88% | +$11.5M | 0.5% | 26 |
|
|
2015
Q2 | $13.7M | Buy |
117,347
+103,659
| +757% | +$11.3M | 0.26% | 79 |
|
|
2015
Q1 | $1.34M | Buy |
13,688
+9,221
| +206% | +$936K | 0.04% | 402 |
|
|
2014
Q4 | $421K | Sell |
4,467
-126,394
| -97% | -$13.1M | 0.02% | 733 |
|
|
2014
Q3 | $13.9M | Buy |
130,861
+121,161
| +1,249% | +$11.9M | 0.64% | 28 |
|
|
2014
Q2 | $804K | Buy |
9,700
+6,300
| +185% | +$490K | 0.03% | 393 |
|
|
2014
Q1 | $241K | Buy |
+3,400
| New | +$267K | 0.02% | 547 |
|
|
2013
Q4 | – | Sell |
-5,472
| Closed | -$344K | – | 1065 |
|
|
2013
Q3 | $344K | Sell |
5,472
-21,828
| -80% | -$1.3M | 0.01% | 602 |
|
|
2013
Q2 | $1.4M | Buy |
+27,300
| New | +$1.42M | 0.08% | 212 |
|
Other funds holding GILD
Paloma Partners's GILD Position: Q3 2024 in Review
Paloma Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 6,700 shares — an estimated $460K sold.
Paloma Partners first reported a position in GILD in Q2 2013 and held it in 33 quarters. The position peaked at $31.4M in Q2 2016. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- Paloma Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 6,700 Gilead Sciences shares in Q3 2024, an estimated $460K.
- Paloma Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 33 quarters.
- Paloma Partners's Gilead Sciences position peaked at $31.4M in Q2 2016.
- 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.